Month: July 2021

Oslo, 23 July 2021: Scatec’s second quarter proportionate revenues was NOK 1,101 million (925) with EBITDA of NOK 601 million (417) and associated EBITDA margin of 55%. Power production more than doubled from the same quarter last year and totaled 860 GWh (406) with strong contributions from the new hydropower assets. The Group’s power production capacity increased by almost 1,500 MW compared to last year. Power Production revenues reached 969 million (458) and EBITDA 660 million (374). Development & Construction’s revenues and EBITDA decreased compared to the same period last year but will be ramping up again in second half of the year when new projects move into construction. “We are experiencing strong market development across all our technology segments with major projects in South Africa and India secured as backlog in the quarter. I...

Press Release July 23, 2021 Signify reports second quarter sales of EUR 1.6 billion, operational profitability of 10.9% and a free cash flow of EUR 104 million Second quarter 20211Signify’s installed base of connected light points increased from 83 million in Q1 21 to 862 million in Q2 21 Sales of EUR 1,609 million; 9.6% nominal sales growth and CSG of 14.1% LED-based sales represented 82% of total sales (Q2 2020: 80%) Adj. EBITA margin improved by 190 bps to 10.9% Net income increased to EUR 82 million (Q2 20: EUR 81 million) Free cash flow of EUR 104 million (Q2 20: EUR 158 million) Net debt/EBITDA ratio of 1.7x (Q2 20: 2.4x)Eindhoven, the Netherlands – Signify (Euronext: LIGHT), the world leader in lighting, today announced the company’s second quarter 2021 results. “In the second quarter we saw an acceleration of the pace...

NEW YORK, July 22, 2021 (GLOBE NEWSWIRE) — Outbrain Inc. (“Outbrain”), announced today the pricing of its initial public offering of 8,000,000 shares of common stock at a price to the public of $20.00 per share. The gross proceeds to Outbrain from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be approximately $160 million. The shares are expected to begin trading on the Nasdaq Global Market on July 23, 2021 under the symbol “OB.” The offering is expected to close on July 27, 2021, subject to customary closing conditions. In addition, the underwriters have been granted a 30-day option to pursue an additional 1,200,000 shares of common stock from Outbrain at the initial public offering price, less underwriting discounts and commissions. Citigroup, Jefferies, Barclays,...

BOCA RATON, Fla., July 22, 2021 (GLOBE NEWSWIRE) — AzurRx BioPharma, Inc. (NASDAQ: AZRX), (“AzurRx” or the “Company”), a clinical stage biopharmaceutical company specializing in the development of targeted, non-systemic therapies for gastrointestinal (GI) diseases, announced today that, due to demand, the underwriter has agreed to increase the size of the previously announced public offering and purchase on a firm commitment basis 9,090,910 shares of common stock of the Company, at a price to the public of $0.55 per share, less underwriting discounts and commissions. The closing of the offering is expected to occur on or about July 27, 2021, subject to satisfaction of customary closing conditions. H.C. Wainwright & Co. is acting as the sole book-running manager for the offering. The Company has granted to the underwriter a...

– Fourth quarter 2020 adjusted sales1 CDN $28.6 million, an increase of 290% over the third quarter– Fourth quarter 2020 revenue of CDN $15.7 million, an increase of 158% over the third quarter– Full Year 2020 adjusted sales1 $37.8 million and Revenue at $23.3 million TORONTO, July 22, 2021 (GLOBE NEWSWIRE) — Red White & Bloom Brands Inc. (CSE: RWB and OTC: RWBYF) (“RWB” or the “Company”) is pleased to report fourth quarter and full year 2020 financial results and is providing certain full year 2020 financial results and select subsequent events. The Company will be filing its 2020 audited financial statements and related Management’s Discussion and Analysis (“MD&A”) today. Management Commentary Brad Rogers, CEO and Chairman stated, “We set out at the beginning of 2020 with a three-year plan...

New safety and efficacy data from both retrospective and prospective studies of the OMNI Surgical System and a prospective study of the TearCare System to be presented MENLO PARK, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Sight Sciences, Inc. (Nasdaq: SGHT), a growth-stage medical device company focused on addressing the underlying causes of the world’s most prevalent eye diseases, today announced that data from multiple retrospective and prospective clinical studies of the OMNI® Surgical System and TearCare® System will be presented at the 2021 American Society of Cataract and Refractive Surgery (ASCRS) Annual Meeting. The in-person conference will take place July 23-27 in Las Vegas. A total of five papers have been accepted for presentation. Details of the presentations are as follows (all times are Pacific Daylight Time...

CALGARY, Alberta, July 22, 2021 (GLOBE NEWSWIRE) — Parkland Corporation (“Parkland”) (TSX:PKI) expects to announce its 2021 second quarter results after markets close on Thursday, August 5, 2021. A conference call and webcast will then be held at 6:30 a.m. MDT (8:30 a.m. EDT) on Friday, August 6, 2021, to discuss the results. To listen to the live webcast and watch the presentation, please use the following link:https://produceredition.webcasts.com/starthere.jsp?ei=1481382&tp_key=85182819cb Analysts and institutional investors interested in participating in the question and answer session of the conference call may do so by calling 1-888-390-0546 (toll-free) (Conference ID: 18980971). International participants can call 1-587-880-2171 (toll) (Conference ID: 18980971). Please connect and log in approximately 10 minutes before...